Cerevance Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
45
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$20M
- Investors
-
14
Cerevance General Information
Description
Developer of novel therapeutics intended for new medicine formulation for central nervous system diseases. The company's therapeutics applies its technology to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle the early onset of various neurological diseases.
Contact Information
Website
www.cerevance.comCorporate Office
- One Marina Park Drive
- Suite 1410
- Boston, MA 02210
- United States
Corporate Office
- One Marina Park Drive
- Suite 1410
- Boston, MA 02210
- United States
Cerevance Timeline
Cerevance Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series C) | 23-Apr-2026 | $20M | Completed | Clinical Trials - Phase 3 | ||
| 6. Secondary Transaction - Private | Completed | Clinical Trials - Phase 3 | ||||
| 5. Later Stage VC (Series B) | 13-Mar-2024 | Completed | Clinical Trials - Phase 3 | |||
| 4. Early Stage VC | 21-Feb-2018 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC | 03-May-2017 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series A) | 02-Dec-2016 | $21.5M | $36M | Completed | Clinical Trials - General | |
| 1. Early Stage VC | $14.5M | $14.5M | Completed | Clinical Trials - General |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cerevance Comparisons
Industry
Financing
Details
Cerevance Competitors (42)
One of Cerevance’s 42 competitors is Cerecin, a Venture Capital-Backed company based in Broomfield, CO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cerecin | Venture Capital-Backed | Broomfield, CO | ||||
| Alzheon | Venture Capital-Backed | Framingham, MA | ||||
| Cognition Therapeutics | Formerly VC-backed | New York, NY | ||||
| Fauna Bio | Venture Capital-Backed | Emeryville, CA | ||||
| CervoMed | Formerly VC-backed | Boston, MA |
Cerevance Patents
Cerevance Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202506133-D0 | Novel compounds | Pending | 24-Apr-2025 | ||
| GB-202502494-D0 | Novel treatment | Pending | 20-Feb-2025 | ||
| WO-2026176180-A1 | Novel treatment | Pending | 20-Feb-2025 | ||
| WO-2026150221-A1 | Combination of cvn-766 and a glp-1 receptor agonist for use in the treatment of obesity and overweight | Pending | 13-Jan-2025 | ||
| WO-2025229336-A1 | Novel process of preparing a trisubstituted pyrazine derivative | Pending | 01-May-2024 | C07D241/20 |
Cerevance Signals
Cerevance Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Agent Capital | Venture Capital | Minority | ||
| Casdin Capital | Venture Capital | Minority | ||
| Dolby Family Ventures | Venture Capital | Minority | ||
| Double Point Ventures | Venture Capital | Minority | ||
| Foresite Capital | Growth/Expansion | Minority |
Cerevance FAQs
-
When was Cerevance founded?
Cerevance was founded in 2016.
-
Where is Cerevance headquartered?
Cerevance is headquartered in Boston, MA.
-
What is the size of Cerevance?
Cerevance has 45 total employees.
-
What industry is Cerevance in?
Cerevance’s primary industry is Drug Discovery.
-
Is Cerevance a private or public company?
Cerevance is a Private company.
-
What is Cerevance’s current revenue?
The current revenue for Cerevance is .
-
How much funding has Cerevance raised over time?
Cerevance has raised $234M.
-
Who are Cerevance’s investors?
Agent Capital, Casdin Capital, Dolby Family Ventures, Double Point Ventures, and Foresite Capital are 5 of 14 investors who have invested in Cerevance.
-
Who are Cerevance’s competitors?
Cerecin, Alzheon, Cognition Therapeutics, Fauna Bio, and CervoMed are some of the 42 competitors of Cerevance.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process